Efficacy of topical 4% liquiritin compared with topical 4% liquiritin mixed in 5% ascorbic acid in the treatment of melasma
Keywords:
Melasma, efficacy, liquiritin, 5% ascorbic acid, MASI scoreAbstract
Objective To compare the efficacy of topical 4% liquiritin alone with combination of topical 4% liquiritin and topical 5% ascorbic acid for the treatment of melasma. Patients and methods This randomized control study was carried out in the Outpatient, Department of Dermatology, Nishtar Hospital, Multan. The duration of the study was six months. Eighty two patients with epidermal melasma belonging to either sex and 16-45 years of age, were divided into two equal groups. Group A was given topical 4% liquiritin and group B was given topical 4% liquiritin mixed with 5% ascorbic acid. Patients were followed up after 8 weeks of treatment to find out the efficacy of both the treatments. Results In group A, 25 (61%) patients showed improvement in MASI score and 16 (39%) had no improvement in MASI score. In group B, 36 (87.8%) patients showed improvement in MASI score and 5 (12.2%) were without improvement in MASI score. The observed difference of MASI score improvement between group A and group B was 26.8% (p<0.05). Conclusion Topical 4% liquiritin mixed in 5% ascorbic acid is more effective than topical 4% liquiritin alone in the treatment of melasma.References
Victor FC, Gelber J, Rao B. Melasma: a review. J Cutan Med Surg. 2004;8:97-102.
Ortonne JP. Melanin pigmentary disorders: treatment update. Dermatol Clin. 2005;23:209-26.
Grimes PE. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation. Cutis. 2004;74:362-8.
Nanda S, Grover C, Reddy BS. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma. Dermatol Surg. 2004;30:385-8.
Bari AU. Efficacy of facial chemical peeling with salicylic acid and role of 4% hydroquinone as an adjuvant treatment modality in melasma. J Pak Assoc Dermatol. 2002;12:183-9.
Chan HH, Kono T The use of lasers and intense pulsed light sources for the treatment of pigmentary lesions. Skin Ther Lett. 2004;9:5-7.
Nordlund JJ, Boissy RE, Hearing VJ et al, editors. The Pigmentary System Physiology and Pathology. New York: Oxford University Press; 1998.
Sanchez NP, Pathak MA, Sato S et al. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol. 1981;4:698-710.
Taylor SC. Epidemiology of skin disease in people of color. Cutis. 2003;71:271-5.
Mashhood AA. Treatment of hyperpigmentation disorders. J Pak Assoc Dermatol. 2006;16:65-8.
Espinal-Perez LE, Moncada B, Castanedo-Cazares JP. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int J Dermatol. 2004;43:604-7.
Huh C-H, Seo K-I, Park J-Y et al. A randomized, double-blind, placebo-controlled trail of vitamin C iontophoresis in melasma. Dermatology. 2003;206:316-20.
Soliman MM, Ramadan SA, Bassiouny DA, Abdelmalek M. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study. J Cosmet Dermatol. 2007;6(2):89-94.
